Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Alliance Women's Research Group LLC
mi
from
Delran, NJ
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Alliance Women's Research Group LLC
mi
from
Delran, NJ
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Lawrence OB-GYN Clinical Research, LLC
mi
from
Lawrenceville, NJ
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Lawrence OB-GYN Clinical Research, LLC
mi
from
Lawrenceville, NJ
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Soffolk OB/GYN
mi
from
Port Jefferson, NY
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Soffolk OB/GYN
mi
from
Port Jefferson, NY
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Eastern Carolina Women's Center
mi
from
New Bern, NC
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Eastern Carolina Women's Center
mi
from
New Bern, NC
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Hawthorne Medical Research, Inc.
mi
from
Winston-Salem, NC
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Hawthorne Medical Research, Inc.
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Unified Women's Clinical Research - Hickory
mi
from
Winston-Salem, NC
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Unified Women's Clinical Research - Hickory
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Women's Health Research
mi
from
Columbus, OH
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Women's Health Research
mi
from
Columbus, OH
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Drexel University
mi
from
Philadelphia, PA
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
TMC Life Research, Inc
mi
from
Houston, TX
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
TMC Life Research, Inc
mi
from
Houston, TX
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Tidwewater Physicians for Women
mi
from
Norfolk, VA
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Tidwewater Physicians for Women
mi
from
Norfolk, VA
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Seattle Women's Health, Research and Gynecology
mi
from
Seattle, WA
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Seattle Women's Health, Research and Gynecology
mi
from
Seattle, WA
Click here to add this to my saved trials
Folic Acid Supplementation in Pregnant Women: Dose Response
Folic Acid Supplementation in Pregnant Women: Dose Response
Status: Enrolling
Updated:  3/1/2018
Athens Regional Medical Center Midwifery Practice
mi
from
Athens, GA
Folic Acid Supplementation in Pregnant Women: Dose Response
Folic Acid Supplementation in Pregnant Women: Dose Response
Status: Enrolling
Updated: 3/1/2018
Athens Regional Medical Center Midwifery Practice
mi
from
Athens, GA
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
The Women's Clinical, P.A.
mi
from
Little Rock, AR
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
The Women's Clinical, P.A.
mi
from
Little Rock, AR
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Unified Women's Clinical Research - Hickory
mi
from
Winston-Salem, NC
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Unified Women's Clinical Research - Hickory
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
TMC Life Research, Inc
mi
from
Houston, TX
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
TMC Life Research, Inc
mi
from
Houston, TX
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Precision Trials AZ
mi
from
Phoenix, AZ
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Precision Trials AZ
mi
from
Phoenix, AZ
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Olympian Clinical Research
mi
from
Clearwater, FL
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Olympian Clinical Research
mi
from
Clearwater, FL
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Women's Medical Research
mi
from
Clearwater, FL
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Women's Medical Research
mi
from
Clearwater, FL
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Hawthorne Medical Research, Inc.
mi
from
Winston-Salem, NC
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Hawthorne Medical Research, Inc.
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Seattle Women's Health, Research and Gynecology
mi
from
Seattle, WA
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Seattle Women's Health, Research and Gynecology
mi
from
Seattle, WA
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Women's Health Care Research Corp.
mi
from
San Diego, CA
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Women's Health Care Research Corp.
mi
from
San Diego, CA
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Altus Research
mi
from
Lake Worth, FL
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Altus Research
mi
from
Lake Worth, FL
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
New Age Medical Research Corporation
mi
from
Miami, FL
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
New Age Medical Research Corporation
mi
from
Miami, FL
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Augusta University
mi
from
Augusta, GA
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Clinical Trials Management
mi
from
Metairie, LA
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Clinical Trials Management
mi
from
Metairie, LA
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Saginaw Valley Medical Research Group, LLC
mi
from
Saginaw, MI
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Saginaw Valley Medical Research Group, LLC
mi
from
Saginaw, MI
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Lawrence OB-GYN Clinical Research, LLC
mi
from
Lawrenceville, NJ
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Lawrence OB-GYN Clinical Research, LLC
mi
from
Lawrenceville, NJ
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Eastern Carolina Women's Center
mi
from
New Bern, NC
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Eastern Carolina Women's Center
mi
from
New Bern, NC
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Tolan Park Clinic
mi
from
Detroit, MI
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Tolan Park Clinic
mi
from
Detroit, MI
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Alliance Women's Research Group LLC
mi
from
Delran, NJ
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Alliance Women's Research Group LLC
mi
from
Delran, NJ
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
ProHEALTH Care Associates LLP
mi
from
Port Jefferson, NY
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
ProHEALTH Care Associates LLP
mi
from
Port Jefferson, NY
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Aventiv Research
mi
from
Columbus, OH
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Aventiv Research
mi
from
Columbus, OH
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Drexel University College of Medicine
mi
from
Philadelphia, PA
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Drexel University College of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Tidewater Clinical Research
mi
from
Norfolk, VA
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Tidewater Clinical Research
mi
from
Norfolk, VA
Click here to add this to my saved trials
Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners
A Pilot Study of an Intimacy-Enhancing Couples Therapy for Men With Advanced Prostate Cancer and Their Partners
Status: Enrolling
Updated:  3/5/2018
Fox Chase Cancer Center - Cheltenham
mi
from
Philadelphia, PA
Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners
A Pilot Study of an Intimacy-Enhancing Couples Therapy for Men With Advanced Prostate Cancer and Their Partners
Status: Enrolling
Updated: 3/5/2018
Fox Chase Cancer Center - Cheltenham
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners
A Pilot Study of an Intimacy-Enhancing Couples Therapy for Men With Advanced Prostate Cancer and Their Partners
Status: Enrolling
Updated:  3/5/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners
A Pilot Study of an Intimacy-Enhancing Couples Therapy for Men With Advanced Prostate Cancer and Their Partners
Status: Enrolling
Updated: 3/5/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated:  3/5/2018
Montgomery Spine Center
mi
from
Montgomery, AL
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated: 3/5/2018
Montgomery Spine Center
mi
from
Montgomery, AL
Click here to add this to my saved trials
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated:  3/5/2018
Community Neurosurgery
mi
from
Indianapolis, IN
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated: 3/5/2018
Community Neurosurgery
mi
from
Indianapolis, IN
Click here to add this to my saved trials
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated:  3/5/2018
Maryland Spine and Brain
mi
from
Annapolis, MD
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated: 3/5/2018
Maryland Spine and Brain
mi
from
Annapolis, MD
Click here to add this to my saved trials
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated:  3/5/2018
Cary Orthopedics
mi
from
Cary, NC
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated: 3/5/2018
Cary Orthopedics
mi
from
Cary, NC
Click here to add this to my saved trials
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated:  3/5/2018
DFW Center for Spinal Disorders
mi
from
Fort Worth, TX
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated: 3/5/2018
DFW Center for Spinal Disorders
mi
from
Fort Worth, TX
Click here to add this to my saved trials
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated:  3/5/2018
Tallahassee Neurological Clinic
mi
from
Tallahassee, FL
MaxAn Post Market Surveillance Validation
A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate
Status: Enrolling
Updated: 3/5/2018
Tallahassee Neurological Clinic
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission
Randomized Phase I Study Combining Suppression of T Regulatory Cells With WT1 Vaccine Therapy for AML Patients in Complete Remission
Status: Enrolling
Updated:  3/7/2018
University of Chicago
mi
from
Chicago, IL
Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission
Randomized Phase I Study Combining Suppression of T Regulatory Cells With WT1 Vaccine Therapy for AML Patients in Complete Remission
Status: Enrolling
Updated: 3/7/2018
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer
An Exploratory Pilot Study of Nab-paclitaxel Based Induction Chemotherapy Followed by Response-Stratified Locoregional Therapy for Patients With Stage III and IV HPV-Related Oropharyngeal Cancer - the OPTIMA HPV Trial
Status: Enrolling
Updated:  3/7/2018
University of Chicago
mi
from
Chicago, IL
Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer
An Exploratory Pilot Study of Nab-paclitaxel Based Induction Chemotherapy Followed by Response-Stratified Locoregional Therapy for Patients With Stage III and IV HPV-Related Oropharyngeal Cancer - the OPTIMA HPV Trial
Status: Enrolling
Updated: 3/7/2018
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma
Nutrition and Anabolic Interventions in Squamous Cell Carcinoma
Status: Enrolling
Updated:  3/8/2018
University of Texas Medical Branch
mi
from
Galveston, TX
Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma
Nutrition and Anabolic Interventions in Squamous Cell Carcinoma
Status: Enrolling
Updated: 3/8/2018
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
TOL-463 Phase 2 Study for Vaginitis
A Randomized Single Blind Safety and Efficacy Study of TOL-463 Vaginal Gel or Insert in the Treatment of Vaginitis (BV and/or VVC)
Status: Enrolling
Updated:  3/8/2018
University of Alabama at Birmingham School of Medicine- Infectious Disease
mi
from
Birmingham, AL
TOL-463 Phase 2 Study for Vaginitis
A Randomized Single Blind Safety and Efficacy Study of TOL-463 Vaginal Gel or Insert in the Treatment of Vaginitis (BV and/or VVC)
Status: Enrolling
Updated: 3/8/2018
University of Alabama at Birmingham School of Medicine- Infectious Disease
mi
from
Birmingham, AL
Click here to add this to my saved trials
TOL-463 Phase 2 Study for Vaginitis
A Randomized Single Blind Safety and Efficacy Study of TOL-463 Vaginal Gel or Insert in the Treatment of Vaginitis (BV and/or VVC)
Status: Enrolling
Updated:  3/8/2018
University of Washington - Harborview Medical Center - Center for AIDS and STD
mi
from
Seattle, WA
TOL-463 Phase 2 Study for Vaginitis
A Randomized Single Blind Safety and Efficacy Study of TOL-463 Vaginal Gel or Insert in the Treatment of Vaginitis (BV and/or VVC)
Status: Enrolling
Updated: 3/8/2018
University of Washington - Harborview Medical Center - Center for AIDS and STD
mi
from
Seattle, WA
Click here to add this to my saved trials